PGE1 Improves Coronary Microcirculation Dysfunction in Patients With CAD and Diabetes
Status:
Unknown status
Trial end date:
2018-03-01
Target enrollment:
Participant gender:
Summary
This study is undertaken to determine if intravenous Lipo-PGE1 therapy would improve coronary
microvascular perfusion in patients with ischemic heart disease by CMRI.